Ajanta Pharma Limited v. Mepfarma India Pvt. Ltd. and Anr.
Case brief
What is this about?
The suit was decreed ex parte against the first defendant who submitted. The second defendant, representing only as a manufacturer, consented to injunctions restraining them from using deceptively similar marks. The court decreed the suit only against the second defendant in terms of prayer clauses (a) and (b).
What did the court decide?
Perpetual injunction restraining defendants from using mark MAX-MOIST or similar marks in medicinal preparations as per prayer clauses (a) and (b).